Bank of America
ASMB icon

Bank of America’s Assembly Biosciences ASMB Stock Holding History

Bank of America’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$303K Buy
10,902
+5,792
+113% +$165K ﹤0.01% 5148
2025
Q4 		$174K Buy
5,110
+1,739
+52% +$56K ﹤0.01% 5404
2025
Q3 		$86.3K Buy
3,371
+3,319
+6,383% +$72.8K ﹤0.01% 6659
2025
Q2 		$942 Buy
52
+13
+33% +$171 ﹤0.01% 7545
2025
Q1 		$373 Buy
39
+2
+5% +$26 ﹤0.01% 7575
2024
Q4 		$584 Sell
37
-307
-89% -$4.94K ﹤0.01% 7384
2024
Q3 		$5.21K Buy
344
+298
+648% +$4.54K ﹤0.01% 7002
2024
Q2 		$631 Buy
+46
New +$656 ﹤0.01% 7309
2024
Q1 		– Sell
-2
Closed -$24 – 7719
2023
Q4 		$24 Buy
+2
New +$19 ﹤0.01% 7620
2023
Q1 		– Sell
-5
Closed -$77 – 7786
2022
Q4 		$77 Sell
5
-2,529
-100% -$43.2K ﹤0.01% 7718
2022
Q3 		$50K Sell
2,534
-32
-1% -$774 ﹤0.01% 6677
2022
Q2 		$65K Sell
2,566
-64
-2% -$1.47K ﹤0.01% 6702
2022
Q1 		$65K Buy
2,630
+1,971
+299% +$42.3K ﹤0.01% 7059
2021
Q4 		$18K Sell
659
-2,252
-77% -$73.8K ﹤0.01% 7547
2021
Q3 		$121K Sell
2,911
-1,664
-36% -$69.7K ﹤0.01% 6613
2021
Q2 		$213K Buy
4,575
+1,971
+76% +$97.6K ﹤0.01% 6058
2021
Q1 		$144K Sell
2,604
-62
-2% -$4.11K ﹤0.01% 6242
2020
Q4 		$193K Buy
2,666
+735
+38% +$86.2K ﹤0.01% 5620
2020
Q3 		$381K Buy
1,931
+433
+29% +$109K ﹤0.01% 4919
2020
Q2 		$420K Sell
1,498
-2,248
-60% -$524K ﹤0.01% 4735
2020
Q1 		$667K Buy
3,746
+1,946
+108% +$417K ﹤0.01% 4302
2019
Q4 		$441K Sell
1,800
-457
-20% -$84.2K ﹤0.01% 5088
2019
Q3 		$266K Sell
2,257
-190
-8% -$28.7K ﹤0.01% 5487
2019
Q2 		$396K Sell
2,447
-4,973
-67% -$945K ﹤0.01% 5221
2019
Q1 		$1.75M Buy
7,420
+3,832
+107% +$970K ﹤0.01% 4096
2018
Q4 		$974K Sell
3,588
-458
-11% -$132K ﹤0.01% 4427
2018
Q3 		$1.8M Sell
4,046
-1,240
-23% -$581K ﹤0.01% 4058
2018
Q2 		$2.49M Buy
5,286
+1,579
+43% +$835K ﹤0.01% 3810
2018
Q1 		$2.19M Buy
3,707
+3,405
+1,127% +$2.11M ﹤0.01% 3808
2017
Q4 		$164K Buy
302
+243
+412% +$110K ﹤0.01% 5502
2017
Q3 		$25K Buy
+59
New +$18.1K ﹤0.01% 6187
2017
Q1 		– Hold
0
– – – 6953
2016
Q4 		– Sell
-86
Closed -$12.8K – 7015
2016
Q3 		$7K Sell
86
-346
-80% -$26.7K ﹤0.01% 6485
2016
Q2 		$29K Buy
432
+399
+1,209% +$26.2K ﹤0.01% 6088
2016
Q1 		$2K Sell
33
-1,364
-98% -$91.2K ﹤0.01% 6763
2015
Q4 		$126K Buy
1,397
+25
+2% +$2.72K ﹤0.01% 5627
2015
Q3 		$157K Buy
1,372
+650
+90% +$114K ﹤0.01% 5458
2015
Q2 		$167K Buy
+722
New +$139K ﹤0.01% 5330
2014
Q4 		– Sell
-417
Closed -$41K – 7663
2014
Q3 		$41K Buy
+417
New +$37K ﹤0.01% 6632
2014
Q1 		– Sell
-8
Closed -$2K – 7770
2013
Q4 		$2K Buy
+8
New +$1.46K ﹤0.01% 7626
2013
Q3 		– Sell
-588
Closed -$85K – 7859
2013
Q2 		$85K Buy
+588
New +$92.2K ﹤0.01% 6242

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Bank of America's ASMB Position: Q1 2026 in Review

Bank of America increased its Assembly Biosciences (ASMB) stake by 113% in Q1 2026, buying an estimated $165K and bringing the position to 10,902 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #5148.

Bank of America first reported a position in ASMB in Q2 2013 and has held it in 40 quarters since. The position peaked at $2.49M in Q2 2018. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • Bank of America held 10,902 shares of Assembly Biosciences worth $303K as of Q1 2026.
  • Bank of America bought 5,792 Assembly Biosciences shares in Q1 2026, an estimated $165K.
  • Assembly Biosciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5148 holding.
  • Bank of America first reported a position in Assembly Biosciences in Q2 2013 and has held it in 40 quarters since.
  • Bank of America's Assembly Biosciences position peaked at $2.49M in Q2 2018.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.